Noubar Afeyan
Noubar Afeyan is number 149 in the 311 Private Wealth Index, with disclosed holdings in listed companies worth about $951m, mainly in Moderna. That is about 4,936 times the wealth of a typical US household. Noubar Afeyan is a director of Moderna.
Part of the 311 Private Wealth Index (311institute.com). Last updated .
Disclosed holdings
| Company | Value | Latest filing | Shares |
|---|---|---|---|
| Moderna | $526m | 22 May 2026 | 2,224,015 at $236.50 (closing price, 15 October 2026) |
| Generate Biomedicines, Inc. | $425m | 2 March 2026 | 26,578,958 at $16.00 |
How this figure is calculated
Shares reported in SEC insider filings (Forms 3, 4 and 5), at the latest holding each filing reports, valued at the latest price disclosed in those filings, or at the latest closing price where no recent trade price was filed. Holdings that the filings say belong to investment funds managed by the person are left out, and shares reported jointly by several family members are counted once. Private companies, cash, property and holdings listed outside the United States are not included, so this is a minimum, not total wealth. The household comparison uses $192,700, the median US household wealth in the Federal Reserve Survey of Consumer Finances (2022, the latest published).
Related
- Moderna in the 311 Titans Index
- Innovation profile of Cambridge
- United States: economy and key statistics
- The 311 Private Wealth Index
- The 311 Titans Index
- All 311 Indexes
Others in the index with Moderna as their main holding
- Stéphane Bancel (#51)
Questions and answers
What is Noubar Afeyan's net worth?
Noubar Afeyan has disclosed holdings in listed companies worth about $951m, according to the 311 Private Wealth Index. This is a minimum: private companies, cash and property are not included.
How much are Noubar Afeyan's disclosed holdings worth?
About $951m in listed companies, ranking Noubar Afeyan number 149 in the 311 Private Wealth Index.
Where does Noubar Afeyan's wealth come from?
Mainly from holdings in Moderna. Noubar Afeyan is a director of Moderna.
Source: SEC insider filings.
© 311 Institute 2026. Facts from official filings and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.